J Robert Kerrey Sells 5,638 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THCGet Free Report) Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Tenet Healthcare Trading Up 0.9%

NYSE:THC traded up $1.63 during trading hours on Friday, hitting $174.83. The company had a trading volume of 1,420,925 shares, compared to its average volume of 1,469,041. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a 50-day moving average of $189.94 and a 200 day moving average of $201.87. The company has a market cap of $15.06 billion, a P/E ratio of 9.09, a P/E/G ratio of 1.14 and a beta of 1.30. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THCGet Free Report) last issued its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period in the prior year, the business earned $4.36 EPS. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on THC shares. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Mizuho upped their price target on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Guggenheim decreased their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Finally, TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Check Out Our Latest Stock Analysis on Tenet Healthcare

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds have recently bought and sold shares of THC. Triumph Capital Management acquired a new position in Tenet Healthcare during the 3rd quarter worth about $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $29,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the 2nd quarter valued at about $35,000. Finally, Meeder Asset Management Inc. raised its position in Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after purchasing an additional 114 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Read More

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.